Chen Yu, TCGX founder and managing partner

As the biotech fund­ing game changed, TCGX al­tered course — and now they’re back with $1B for round two

When Chen Yu and his team at TCGX set out in ear­ly 2021 with some $800 mil­lion to in­vest in biotech, he …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.